GRP
PLRX icon

Global Retirement Partners’s Pliant Therapeutics PLRX Stock Holding History

Global Retirement Partners’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5 Hold
4
– – ﹤0.01% 4216
2025
Q3 		$6 Hold
4
– – ﹤0.01% 3854
2025
Q2 		$5 Buy
+4
New +$6 ﹤0.01% 3793
2024
Q4 		$53 Hold
4
– – ﹤0.01% 3583
2024
Q3 		$45 Hold
4
– – ﹤0.01% 3449
2024
Q2 		$43 Buy
+4
New +$52 ﹤0.01% 3491

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Global Retirement Partners's PLRX Position: Q4 2025 in Review

Global Retirement Partners held its Pliant Therapeutics (PLRX) position steady in Q4 2025 at 4 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #4216.

Global Retirement Partners first reported a position in PLRX in Q2 2024 and has held it in 6 quarters since. The position peaked at $53 in Q4 2024. 96 funds tracked by Wall St. Rank hold PLRX as of Q4 2025.

  • Global Retirement Partners held 4 shares of Pliant Therapeutics worth $5 as of Q4 2025.
  • Global Retirement Partners left its Pliant Therapeutics share count unchanged in Q4 2025.
  • Pliant Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #4216 holding.
  • Global Retirement Partners first reported a position in Pliant Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Global Retirement Partners's Pliant Therapeutics position peaked at $53 in Q4 2024.
  • 96 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.